Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study.

Jang-Whan Bae Kyoung Hwa Ha Junyoung Lee Sangshin Park Kyeong Seok Oh Dae-Hwan Bae Ju-Hee Lee Sang Min Kim Woong Gil Choi Kyung Kuk Hwang Dong-Woon Kim Myeong-Chan Cho Dae-Jung Kim Jang-Whan Bae

Published in: Korean circulation journal (2024)

In this nationwide cohort study of individuals with type 2 diabetes, treatment with SGLT2i was associated with a lower risk of AF compared with treatment with DPP-4i.

Keyphrases

atrial fibrillation
heart failure
left atrial
catheter ablation
percutaneous coronary intervention
replacement therapy
direct oral anticoagulants
smoking cessation